Company ProfilePremium

Memiontec Holdings Ltd.

Company Profile Analysis

明泰控股

ESOMAR 23 Corporate BadgeISO Certifications Badge
Memiontec Holdings Ltd. - Company showcase

Year Founded & Workforce

1992

Memiontec Holdings Ltd. logo

Memiontec Holdings Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Memiontec Holdings Ltd. Overview

MetricFY2022FY2023FY2024FY2025
Employee wages and benefits (S$ M)6.67.69.40

Note: the FY2025 figure is shown as 0 only because the Group did not publish the economic-value-distributed table in the AR2025 extract reviewed; treat FY2025 as not publicly disclosed. G&A payroll costs were S$1.89M in FY2024 and S$1.58M in FY2025 (FY2025 results), and fell a further 37.5% year on year in 1H2026.

Memiontec is a Singapore-headquartered, founder-controlled micro-cap water engineering group that designs, builds, operates and, in Indonesia, co-owns water and wastewater treatment assets. The company built its reputation as a membrane and MEICA (Mechanical, Electrical, Instrumentation, Control and Automation) contractor to Singapore's national water agency PUB, delivering packages at Tuas South Desalination Plant, Kranji NEWater, Changi Water Reclamation Plant Phase 2 and the Deep Tunnel Sewerage System Phase 2. In Indonesia it combines EPC work with minority and majority equity stakes in five BOOT/TOOT concessions, partnered with state-linked entities such as Jakarta Propertindo, PT PP Infrastruktur and ITDC. The business peaked at S$66.9M revenue in FY2023, then fell into consecutive losses as fixed-price PUB contracts suffered prolonged construction and cost overruns. With S$2.8M of attributable equity at 30 June 2026, covenant waivers in place and reliance on CEO loans, Memiontec is now a balance-sheet repair and recurring-income transition story rather than a growth story.


Company's own description

In its Annual Report 2025, Memiontec describes itself as a one-stop water technology total solutions provider with more than 30 years in the water industry. It combines membrane filtration, ion exchange, and physical, chemical and biological treatment processes with in-house design, customised engineering and turnkey implementation. It states a presence in Singapore, Indonesia, China and Vietnam, serving both municipal and industrial customers. The company also says it creates shareholder value through long-term BOOT (Build-Own-Operate-Transfer) and TOOT (Transfer-Own-Operate-Transfer) investments that generate recurring income (AR2025, "About Us").

Business model and revenue model

The Group reports four segments that together span the water value chain:

  1. TSEPC (Total Solutions with Engineering, Procurement and Construction) is project-based, fixed-price contracting, with revenue recognised over time by stage of completion. It accounted for 83.8% of FY2025 revenue and 93.9% of FY2024 revenue (AR2025 Operating and Financial Review).

  2. OMS (Operations, Maintenance and Services) is service revenue recognised over time. Contracts typically run 1–3 years. OMS on the Group's BOOT/TOOT concessions runs 20–25 years (AR2025 Synergistic Business Model).

  3. SDS (Sales and Distribution of Systems and Equipment, including trading) is product revenue recognised at a point in time. It covers modular systems, components, chemicals and membranes, including products sold as an authorised distributor.

  4. SOW (Sales of Water) is recurring, concession-style revenue from BOOT/TOOT projects where the Group is owner or co-owner. It is recognised at a point in time. A material part of the economic value sits outside consolidated revenue because several concessions are equity-accounted JVs or FVOCI investments.

Revenue mix by nature, FY2025 (S$'000, FY2025 results announcement): project/service revenue recognised over time was 23,260 (TSEPC 21,753 + OMS 1,507), or 89.6%. Product and water revenue recognised at a point in time was 2,688 (SDS 2,230 + SOW 458), or 10.4%. The company has no subscription or licensing revenue.

Value-chain position

Memiontec sits in the midstream of the water value chain. It buys membranes, pumps, piping, instrumentation and civil/M&E subcontract services, adds in-house process design, PLC/control engineering and fabrication, and delivers turnkey plants. Downstream, it captures operating income through OMS and, in Indonesia, tariff-type income through concessions. It owns no membrane manufacturing IP. Its differentiation rests on process design know-how, licensing (BCA ME11 Grade L6 in Singapore; B1/B2 construction licences in Indonesia), and long-standing relationships with PUB and Indonesian state-linked partners (AR2024 Chairman and CEO's Message).

Customer types and end-markets

Singapore public sector: PUB is the dominant Singapore customer. Named projects include the C22C MBR contract at Changi WRP Phase 2 (S$56.6M), DTSS Phase 2 odour control and air jumper facilities (S$21.7M), Tuas South Desalination Plant ultrafiltration (S$33.2M), and Jurong Island STP M&E replacement.

Singapore other institutional: Mandai Wildlife (penguin exhibit and bird park life-support systems) and Semakau Landfill (NEA-related floating wastewater treatment and power generation system).

Indonesian municipal: city water and sewerage agencies (Palembang, Makassar, Jambi, Pekanbaru, Jakarta via PAM Jaya/Jakpro) and the tourism-estate utility ITDC (Nusa Dua, Bali).

Indonesian industrial: agro-industry and palm oil (Dumai, WPS biodiesel effluent), food and beverage (Indolakto), mining (Amman Mineral townsite RO; Adaro intake relocation), and industrial estates (Suryacipta).

China: trading of components through MIT Water Technology (Chengdu). Revenue is negligible (S$11k in FY2023; nil in FY2024–FY2025).

Vietnam: a subsidiary was incorporated in October 2022 for construction of water supply and drainage systems. No disclosed revenue to date.

Independent characterisation

Memiontec is best understood as a sub-scale, founder-run specialty water contractor whose earnings are dominated by a small number of large, lumpy, fixed-price public tenders in Singapore. It also has a slower-burn Indonesian portfolio of co-owned concessions. The Singapore franchise is technically credible: the Group is one of the few local SMEs with unlimited-value ME11 L6 registration. However, the FY2024–FY2025 losses show that the Group carried construction-period and cost-escalation risk it could not pass through. The C22C and DTSS2 contracts, won in 2021–2022, absorbed post-pandemic labour, material and financing inflation. Indonesia has been the steadier contributor, but it generates modest absolute profits, carries IDR translation risk, and relies on contractual "Combination Agreements" rather than direct equity ownership for control of PT Memindo Pratama. The investment case now hinges on (i) collection of final accounts and certification of unrecognised variation orders on the Singapore projects, (ii) commercial operation of the Bali desalination BOOT and Tanah Merah BOOT, and (iii) whether the balance sheet can be stabilised without further heavy dilution.

Strategy

Stated strategy (themes from AR2024 and AR2025)

  1. Recurring income through concessions. The Group aims to grow recurring income from BOOT/TOOT service-concession projects in Asia, positioning itself as owner or co-owner rather than pure contractor. It is currently co-owner in five Indonesian projects.

  2. Scale up project size in Indonesia by partnering with local and overseas companies for larger EPC tenders in government and private industrial sectors, and by bidding for new BOOT projects.

  3. Disciplined Singapore tendering. The Group continues to tender for PUB and private membrane and MEICA work, but AR2025 and the 1H2026 commentary put greater emphasis on project risk assessment, commercial viability, contract terms and expected returns.

  4. SDS expansion. This includes broadening distribution channels, securing regional distribution rights, scaling the Memiontec-brand standard systems, and integrating PRC sourcing to reduce cost of goods.

  5. Regional expansion into Vietnam (50-year water concession models cited) and Cambodia through investment, JV and partnership.

  6. Funding and M&A. AR2024 lists fundraising, strategic investors and M&A as strategic levers, and mentions tapping Indonesia's capital market through the PT MIT Investment Indonesia structure.

  7. Liquidity first (AR2025). Management now prioritises cash-flow management, working-capital discipline, collection of final accounts and VO claims, and both equity and debt fundraising.

Initiatives announced in the last 24 months

DateInitiativeDetailStatus
Oct 2024Minority stake in PT Tirta Mitra AbadiVehicle for new BOOT/TOOT tenderingOngoing; no project announced
2,024PTMP office expansion; larger SDS sales teamSupports Indonesian SDS growth and PRC supply-chain integrationCompleted
Dec 2024 – May 2025Rights cum warrants issue440.5M rights shares at S$0.009; 704.8M warrants at S$0.003 (exercise could add ≈S$2.1M if fully exercised)Completed; 44.8M warrants exercised by 30 Jun 2026
Apr 2025Finance leadership successionCFO role replaced by a Financial Controller; former CFO moved to non-executive board seatCompleted
2,025Bali BOOT testing and commissioning water salesSOW revenue S$458k in FY2025; S$631k in 1H2026Commercial operation date not yet announced
2,025Tanah Merah BOOT construction completed42% stakeOperating status and COD not separately announced
2025–2026VO claims on Singapore projectsSubmitted; not recognised in accounts or cash-flow projectionsPending certification
2025–2026Cost programmeLower headcount, dormitory and overhead costs; G&A −27.8% in 1H2026Ongoing; no quantified target
1H2026Lender negotiationsOne-off covenant waivers; scheduled debt reductionOngoing

ESG commitments and targets (AR2025)

  • Execute or complete at least three TSEPC projects in municipal and industrial sectors (FY2026 target; met in FY2024).

  • Maintain at least 50% of procurement with local suppliers (FY2026), rising to at least 90% beyond 2030. Achieved 95.6% in FY2025.

  • No significant operational disruptions from adverse climate conditions (met in FY2025).

  • Monitor Scope 1 and 2 emissions; collect Scope 3 data by 2030; progressively align with TCFD and prepare for ISSB (IFRS S1/S2).

Medium-term financial targets / guidance

None disclosed. The Group publishes no revenue, margin or return targets. Its only forward-looking statements are qualitative (order book completion within two years; VO certification; continued tendering).

Products & Services

Memiontec does not publish a priced product catalogue. The table below lists every product line, solution type and flagship reference project in its annual reports and contract announcements. Pricing is not publicly disclosed for any line. TSEPC is priced by tender or lump-sum contract, OMS by service contract, SDS by unit sale, and SOW by concession tariff (tariffs not disclosed).

TSEPC — solution lines

Solution lineDescription / technologiesTarget customersFlagship references (capacity; status)Source
Water treatment plantsClarification, gravity filtration, UF, RO; potable and process waterMunicipal water agencies; industrial estates; mining townsitesOloboju WTP rehabilitation (300 L/s, Indonesia); Suryacipta industrial WTP (5,000 m³/day); Amman townsite RO WTP (1,500 m³/day); Tarjun WTP upgrade (to 250 m³/hour); IKK MEIA installation (120,000 m³/day)AR2025 project portfolio
Wastewater / water reclamationMBR, MBBR, aerobic reactors, anaerobic treatment, UV, sand and carbon filtration, high-rate clarificationMunicipal sewerage; F&B; palm oil and biodieselChangi WRP Phase 2 C22C MBR (22 MGD; ~1,736 L/s per AR; S$56.6M; Phase A substantially completed 2025); Jurong WRP MBR (787 L/s); Changi WRP high-rate clarification (2,300 L/s); Palembang STP (230 L/s); Makassar WWTP (185 L/s); Jambi WWTP (88 L/s); Indolakto WWTP (MBBR/UF/RO, 10 L/s); WPS biodiesel effluent (50 m³/day, anaerobic); FOI WWTP upgrade (300→600 m³/day)AR2025; C22C announcement (24 Mar 2022)
Water recycling (NEWater)Pressurised microfiltration, RO membranesPUBKranji NEWater Factory: RO (900 L/s), MF (1,193 L/s), pressurised MF and RO (266 L/s)AR2025
Seawater desalinationUF pre-treatment, SWRO, polishingPUB; tourism estatesTuas South Desalination Plant UF (8,800 L/s; S$33.2M; completed 2021); Nusa Dua SWRO BOOT (10,000 m³/day per contract announcement)AR2025; Bali announcement (24 Oct 2023)
DisinfectionElectrochlorination; chlorine contact tanksPUBBedok Waterworks electrochlorination and chlorine contact tank (1,578 L/s each)AR2025
Odour control / sewer MEICAOdour control and air jumper facilities; MEICA worksPUBDTSS Phase 2 Odour Control & Air Jumper Facilities (S$21.7M; substantially completed 2025)SGXNet (Apr 2021); AR2025
M&E replacementMechanical and electrical equipment replacementPUBJurong Island Sewage Treatment Plants 1 & 2The Edge (Aug 2021); AR2025
Specialty systemsAnimal life-support systems; floating WTP with power generationZoological parks; landfillMandai penguin exhibit life support (388 L/s); Mandai Bird Park life support (2018); Semakau Landfill WWTP and power generation (208 L/s)AR2025
Pipeline and intake worksHDPE transmission pipelinesMunicipal/miningIKK intake pipeline (8 km); Adaro intake relocation (8 km HDPE)AR2025
Plantation WTP/WWTPDesign-build water and wastewater plantsPlantationsDumai WTP (350 m³/day) and WWTP (590 m³/day)AR2025
PAM Jaya water treatmentMBBR and UFJakarta water utilityPAM Jaya WTP (10 L/s); PAM Jaya Mookervaart WTP at Daan MogotAR2025; AGM 2021 slides

OMS — service lines

ServiceDescriptionContract tenorSource
Plant operationsOperation of municipal/industrial plants, including concession plants1–3 years (standard); 20–25 years (concessions)AR2025
Preventive and corrective maintenanceScheduled and breakdown maintenance of MEICA and membrane systems1–3 yearsFY2025 results note 10
Technical support and consultationProcess optimisation, troubleshootingAd hocAR2025
Interim care and maintenancee.g. DTSS2 MEICA equipment during the interim periodProject-linkedThe Edge (Apr 2021)
Data-driven optimisationPLC-based data collection from OMS and concession plants to lower operating costEmbeddedAR2024

SDS — product lines

Product lineDescriptionSource
Standard Memiontec-brand systemsStandardised treatment units sold under the Memiontec brand; two registered trademarks (IPOS Class 7, Feb 2023–Apr 2033; Class 11, Mar 2024–Sep 2034)AR2024; AR2025 certification table
Modular and customised systemsSkid-mounted water treatment facilitiesAR2025
Containerised desalination plantsMobile/containerised RO unitsAR2025
Water treatment equipment and componentsPumps, valves, instrumentation, spare partsAR2025
ChemicalsSpecialty and blended treatment chemicalsRoic.ai profile; AR2025
Membranes and mediaSold as an authorised distributor (principal brands not disclosed in sources reviewed)Roic.ai profile
PRC-sourced componentsProcurement and trading via MIT Water (Chengdu), integrated into Indonesian SDS supply chainAR2024

SOW — concession assets (BOOT/TOOT)

ProjectTypeLocationMemiontec interest (partner)CapacityConcessionStatusAccounting
Hutan KotaBOOTJakarta40% via PT Jakpro Memiontec Air (PT JUP 60%)500 L/s (43,200 m³/day) per AR2025; FY2022 results cite a 450 L/s design capacity at Phase 2 — discrepancy20+5 years from 2019Operating since Dec 2019Equity-accounted JV
Waduk PluitTOOTJakarta40% via KSO JUP MIT (PT JUP 60%)Up to 2,500 m³/day25 years from 2018Operating since 2018Joint operation
PekanbaruBOOTRiau15% in PT PP Tirta Madani (PT PP 85%)Up to 750 L/s25 yearsPhase 1 upgrading completed 2022FVOCI financial asset (S$2.05M at 30 Jun 2026)
Tanah MerahBOOTJakarta42% in PT PP Tirta Tanah Merah (PT PP 51%, PT KCP 7%)200 L/s per AR2025 (the Sep 2023 announcement says "200 litres per day," apparently a typographical error)20 years from commercial operation dateConstruction completed 2025Shown as a JV in the corporate structure chart
Nusa Dua, BaliBOOTBali80% via KSO Memiontec–BSBK / PT Memiontec Bakti Bali (PT Bayu Surya Bakti Konstruksi 20%)10,000 m³/day per contract announcement; AR2025 shows 46 L/s (≈3,974 m³/day) — likely an initial phase; discrepancy unresolvedAt least 15 years (AR); 25 years of water sales cited in milestonesConstruction in progress; water sold during testing and commissioning since 2H2025Consolidated (SOW revenue; contract assets)

Financial Narrative

All figures are audited unless stated otherwise. FY2021–FY2024 are audited figures as re-presented in subsequent announcements and Annual Reports 2024/2025. FY2025 balance sheet and P&L are per the unaudited FY2025 announcement (28 Feb 2026), confirmed as unchanged by the audited 31 Dec 2025 comparatives in the 1H2026 results and the AR2025 five-year summary.

Income statement: notes and sources

Sources: FY2022 results (FY2021 audited); FY2023 results (FY2022 audited comparatives — note the unaudited FY2022 announcement had shown operating profit of S$3,538k and net profit of S$2,600k); FY2024 results (FY2023 audited); FY2025 results (FY2024 audited); AR2025 five-year summary. EBITDA is an analyst computation (operating profit plus depreciation of PPE and right-of-use assets).

Per-share data

Sources: results announcements FY2022–FY2025; AR2025. Data-quality flags: (i) the AR2025 rights-adjusted FY2021 EPS of 0.40 cents does not reconcile with FY2021 attributable profit of S$1.53M on any disclosed share base and should be treated with caution; (ii) the FY2021 dividend was declared as 0.209 cents on the pre-split base of 220,257,000 shares (≈0.070 cents split-adjusted; total S$460k); (iii) FY2024 NAV is shown on the rights-adjusted share count (1.21 cents); on the pre-rights base it was 2.09 cents (AR2024).

Margins and growth

FY2021 growth is computed against FY2020 revenue of S$34,606k (AR2024 five-year summary).

Revenue CAGR: FY2021–FY2025 (4 years): −13.2% per annum. FY2020–FY2025 (5 years): −5.6% per annum (analyst computation).

Balance sheet

Sources: FY2022–FY2025 results; AR2024 and AR2025 five-year summaries. Data-quality flags: (i) the unaudited FY2023 announcement showed cash of S$14,696k and total current assets of S$50,250k; audited figures are S$13,967k and S$49,521k; (ii) the unaudited FY2024 announcement showed total assets of S$48,328k and equity of S$12,895k; the audited FY2024 figures (S$49,423k; S$13,990k) include a S$1,095k FVOCI fair-value gain on the Pekanbaru (PPTM) stake; (iii) goodwill and intangibles are not separately presented in the condensed statements and appear immaterial; (iv) negative net debt denotes a net cash position.

Interim balance sheet update (30 June 2026, unaudited, 1H2026 results): cash S$6,809k; contract assets S$11,056k; total assets S$28,248k; borrowings S$7,755k (current S$3,806k; non-current S$3,949k); lease liabilities S$342k; equity attributable S$2,826k; total equity S$3,181k; net current assets S$2,927k; group NAV 0.25 cents per share; D/E 2.55x.

Cash flow

Sources: FY2022 results (FY2021); FY2023 results (FY2022); FY2024 results (FY2023 audited OCF of −S$4,283k; the unaudited FY2023 announcement showed −S$4,170k); FY2025 results. FY2023 equity injections comprise S$729k into the Tanah Merah JV and S$219k into PPTM. FY2025 director loans are shown gross; S$120k of prior advances was repaid. The FY2025 rights proceeds shown are cash proceeds; total net share-capital increase was S$3,934k because S$1.78M was set off against sums owed to the CEO.

1H2026 cash flow: operating cash inflow S$3,363k, driven by S$7,063k of contract-asset collections; capex S$54k; net borrowings repaid S$2,809k; director loans received S$2,000k; cash and cash equivalents S$5,922k at period end (1H2026 results).

Key ratios

Methodology (analyst computations unless noted): ROE uses average attributable equity (FY2020 opening equity S$17,079k). Company-reported ROE is from AR2024; the company computed FY2024 ROE on unaudited year-end equity, and no FY2025 ROE was published (shown as 0 = not disclosed). ROA uses total net profit and average total assets (FY2020 total assets S$37,464k). ROIC = operating profit × (1 − effective tax rate) ÷ year-end invested capital (equity + borrowings + leases − cash); no tax shield is applied in loss years. D/E: the AR2025 gearing ratio of 1.74x matches this computation, but the FY2025 results announcement narrative cited 1.2x — an unexplained internal inconsistency in the filings. Net debt/EBITDA: the Group was net cash in FY2021–FY2023 (net cash/EBITDA of 4.2x, 2.4x and 0.6x respectively); the ratio is not meaningful for FY2024–FY2025 because EBITDA was negative. Days are year-end balances over annual revenue or cost of sales × 365.

Commentary on trends, inflections and drivers

FY2021–FY2023 — growth on the back of PUB wins. Revenue rose from S$45.6M to a record S$66.9M as the Group executed TSDP, DTSS2 and then C22C. FY2022 was the margin peak (gross margin 20.2%). Pandemic-delayed Indonesian projects resumed that year, and Indonesia contributed 60.7% of revenue at higher margins (FY2022 results). In FY2023 Singapore's share jumped to 74.9%, and gross margin fell 6.3 percentage points. The FY2023 results attributed the fall partly to higher financing costs from rising interest rates.

Working-capital inflection (FY2023). Contract assets more than doubled to S$27.1M as completed but uncertified PUB work accumulated. Operating cash flow turned negative (−S$4.3M), and the Group drew down S$12.7M of revolving credit. Gearing rose from 0.22x to 0.52x. This was the first visible sign of the liquidity strain that followed.

FY2024 — the profitability break. Revenue fell 20.8%, and the Group booked a S$1.36M gross loss as budgets on the "Ongoing Projects" (C22C and DTSS2) were revised for prolonged construction, supply-chain disruption, and higher materials, manpower and finance costs (FY2024 profit guidance, Feb 2025). 2H2024 alone showed a 24.3% gross loss margin. Operating cash outflow reached S$10.0M. Borrowings rose to S$15.6M, all current, after a covenant breach required reclassification. The S$1.3M FY2023 dividend paid in FY2024 compounded the cash drain.

FY2025 — shrinking and recapitalising. Revenue halved to S$25.9M as the Singapore projects neared completion. The FY2025 gross loss margin (6.5%) was smaller in absolute terms than in 2H2024, but finance costs quadrupled to S$1.07M (bank, third-party and 12% director loans). The JV share of loss widened to S$0.62M on lower Hutan Kota water volumes. An IDR-driven S$1.47M translation loss pushed total comprehensive loss to S$10.8M. The S$3.8M rights issue only partially offset this. Equity halved to S$7.2M.

1H2026 — cash positive, equity near exhaustion. Collection of contract assets (−S$7.6M) generated a S$3.4M operating cash inflow, and borrowings were cut to S$7.8M. G&A fell 27.8% on lower headcount and dormitory costs. However, revenue fell another 51.8% to S$7.7M, gross loss widened to 7.4%, and attributable equity fell to S$2.8M. Net current assets fell to S$2.9M. The Board's going-concern assessment relies on expected project cash flows, receivable collections, ongoing lender discussions, cost cuts and "continued financial support from the Group's controlling shareholder where required" (1H2026 results, note 1).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentDefinitionPrincipal entities

TSEPC

Total solutions with engineering, procurement and construction services for water and wastewater management

Memiontec Pte Ltd (Singapore); PT Memiontec Indonesia

OMS

Operations and preventive/corrective maintenance services for water and wastewater plants

Memiontec Pte Ltd; PTMI

SDS

Sales and distribution of water treatment systems, and trading

PTMI / PTMP (Indonesia); MIT Water (PRC)

SOW

Sale of water and other recurring revenue under long-term concession arrangements

PTMI / PT Memiontec Bakti Bali (Nusa Dua BOOT, 80%)

Segment revenue (SGD K)

Segment revenue (SGD K)FY2021FY2022FY2023FY2024FY2025

TSEPC revenue (SGD K)

41,60439,05163,63449,68221,753

OMS revenue (SGD K)

3,3712,7852,3491,6401,507

SDS revenue (SGD K)

4567476841,4652,230

SOW revenue (SGD K)

214204183127458

Total revenue (SGD K)

45,64542,78766,85052,91425,948

Results by Segment

Segment result (SGD K)FY2021FY2022FY2023FY2024FY2025

TSEPC segment result (SGD K)

2,9304,7085,636-5,563-6,125

OMS segment result (SGD K)

493565414162269

SDS segment result (SGD K)

209314207397348

SOW segment result (SGD K)

1097725788

Total segment result (SGD K)

3,7415,6646,282-4,997-5,420

Segment margin (%)

Segment margin (%)FY2021FY2022FY2023FY2024FY2025

TSEPC segment margin (%)

7.012.18.9-11.2-28.2

OMS segment margin (%)

14.620.317.69.917.8

SDS segment margin (%)

45.842.030.327.115.6

SOW segment margin (%)

50.937.713.75.519.2

Segment share of revenue (%)

Segment share of revenue (%)FY2021FY2022FY2023FY2024FY2025

TSEPC share (%)

91.191.395.293.983.8

OMS share (%)

7.46.53.53.15.8

SDS share (%)

1.01.71.02.88.6

SOW share (%)

0.50.50.30.21.8

Segment YoY growth (%)

Segment YoY growth (%)FY2022FY2023FY2024FY2025

TSEPC growth (%)

-6.163.0-21.9-56.2

OMS growth (%)

-17.4-15.7-30.2-8.1

SDS growth (%)

63.8-8.4114.252.2

SOW growth (%)

-4.7-10.3-30.6260.6

Revenue by Segment

Segment (SGD K)1H20251H2026

TSEPC revenue (SGD K)

14,6305,489

OMS revenue (SGD K)

841718

SDS revenue (SGD K)

322814

SOW revenue (SGD K)

78631

TSEPC result (SGD K)

-2,224-1,851

OMS result (SGD K)

195-6

SDS result (SGD K)

20-129

SOW result (SGD K)

14201

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income statement (SGD K)

Income statement (SGD K)FY2021FY2022FY2023FY2024FY2025

Revenue (SGD K)

45,64542,78766,85052,91425,948

Cost of sales (SGD K)

39,31834,15457,56554,27427,623

Gross profit (SGD K)

6,3278,6339,285-1,360-1,675

Other income (SGD K)

560231323475265

General and administrative expenses (SGD K)

4,7485,3645,4515,4755,638

Operating profit (SGD K)

2,1393,5004,157-6,360-7,048

Depreciation of PPE and ROU assets (SGD K)

318357351431413

EBITDA excl. JV share (SGD K)

2,4573,8574,508-5,929-6,635

Finance costs (SGD K)

1401221272431,070

Share of JV profit or loss (SGD K)

87128-110-384-620

Profit before tax (SGD K)

2,0863,5063,920-6,987-8,738

Income tax expense (SGD K)

545936683401544

Net profit total (SGD K)

1,5412,5703,237-7,388-9,282

Net profit attributable to owners (SGD K)

1,5332,5513,235-7,390-9,473

Per-share data

Per-share dataFY2021FY2022FY2023FY2024FY2025

Basic EPS as reported post-split basis (S$ cents)

0.230.390.49-1.12-0.83

Basic EPS rights-adjusted per AR2025 (S$ cents)

0.400.220.28-0.65-0.83

Diluted EPS as reported (S$ cents)

0.230.390.49-1.12-0.83

Dividend per share declared for year split-adjusted (S$ cents)

0.0700.1180.19600

NAV per share as reported at year end (S$ cents)

2.752.923.271.210.59

Margin and growth metric (%)

Margin and growth metric (%)FY2021FY2022FY2023FY2024FY2025

Gross margin (%)

13.920.213.9-2.6-6.5

Operating margin (%)

4.78.26.2-12.0-27.2

EBITDA margin (%)

5.49.06.7-11.2-25.6

Net margin attributable (%)

3.46.04.8-14.0-36.5

Revenue growth YoY (%)

31.9-6.356.2-20.8-51.0

Balance Sheet

Balance sheet (SGD K)FY2021FY2022FY2023FY2024FY2025

Cash and bank balances (SGD K)

15,45113,33413,9679,0556,305

Trade and other receivables (SGD K)

8,4958,0205,8576,7556,459

Contract assets (SGD K)

6,00911,75627,13226,79418,630

Inventories (SGD K)

146322,56513931

Total current assets (SGD K)

30,10133,14249,52142,74331,425

Total non-current assets (SGD K)

5,3755,0915,6816,6805,284

Total assets (SGD K)

35,47638,23355,20249,42336,709

Trade and other payables (SGD K)

10,31212,89219,79416,37914,843

Short-term borrowings (SGD K)

1,1551,4319,72615,5749,360

Long-term borrowings (SGD K)

3,5662,3871,18202,678

Total borrowings (SGD K)

4,7213,81810,90815,57412,038

Lease liabilities (SGD K)

505443336757438

Net debt incl. leases (SGD K)

-10,225-9,073-2,7237,2766,171

Total current liabilities (SGD K)

13,04815,89031,81834,53126,091

Total non-current liabilities (SGD K)

4,2042,9761,7229023,447

Total liabilities (SGD K)

17,25218,86633,54035,43329,538

Share capital (SGD K)

12,09212,09212,09212,09216,026

Equity attributable to owners (SGD K)

18,17419,30721,60213,8216,791

Total equity (SGD K)

18,22419,36721,66213,9907,171

Net current assets (SGD K)

17,05317,25217,7038,2125,334

Cash flow (SGD K)

Cash flow (SGD K)FY2021FY2022FY2023FY2024FY2025

Operating cash flow (SGD K)

2,959346-4,283-9,964-1,757

Capex purchase of PPE (SGD K)

36591684411

Free cash flow (SGD K)

2,594255-4,351-10,008-1,768

Equity injections into BOOT investees (SGD K)

560112948068

Dividends paid (SGD K)

4074607801,2950

Share buybacks (SGD K)

00000

Proceeds from bank borrowings (SGD K)

90025012,66230,09311,987

Repayments of borrowings (SGD K)

1,2161,1535,57225,44915,527

Loans and advances from directors (SGD K)

0002,1202,000

Proceeds from rights cum warrants issue (SGD K)

00002,154

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2021FY2022FY2023FY2024FY2025

ROE on average attributable equity (%)

8.713.615.8-41.7-91.9

ROE as reported by company (%)

8.413.215.0-58.10

ROA on average total assets (%)

4.27.06.9-14.1-21.6

ROIC analyst estimate (%)

19.824.918.1-29.9-52.8

Current ratio (x)

2.312.091.561.241.20

Debt to equity incl. leases (x)

0.290.220.521.171.74

Interest coverage EBIT to finance costs (x)

15.328.732.7-26.2-6.6

Asset turnover (x)

1.251.161.431.010.60

DSO incl. contract assets (days)

116169180231353

Inventory days (days)

101610

DPO (days)

96138126110196

Cash conversion cycle proxy (days)

213170122157

Geographic revenue (SGD K)

Geographic revenue (SGD K)FY2021FY2022FY2023FY2024FY2025

Singapore revenue (SGD K)

31,61916,80050,04434,55910,395

Indonesia revenue (SGD K)

13,98525,97116,79518,35515,553

China revenue (SGD K)

41161100

Revenue by Region (%) and Region Margins & Growth (%)

Geographic metric (%)FY2021FY2022FY2023FY2024FY2025

Singapore share of revenue (%)

69.339.374.965.340.1

Indonesia share of revenue (%)

30.660.725.134.759.9

Singapore revenue growth (%)

0-46.9197.9-30.9-69.9

Indonesia revenue growth (%)

085.7-35.39.3-15.3

Geographic revenue (SGD K) (1H2024–1H2026)

Geographic revenue (SGD K)1H20241H20251H2026

Singapore revenue (SGD K)

22,9265,4923,933

Indonesia revenue (SGD K)

7,11910,3793,719

TSEPC revenue by country (SGD Mn)

TSEPC revenue by country (SGD Mn)FY2022FY2023FY2024

TSEPC Singapore (SGD Mn)

13.048.332.9

TSEPC Indonesia (SGD Mn)

26.015.216.7

Non-current segment assets (SGD K)

Non-current segment assets (SGD K)FY2021FY2022FY2023FY2024FY2025

Singapore non-current assets (SGD K)

763707538564293

Indonesia non-current assets (SGD K)

4,4704,3035,0685,9904,873

China non-current assets (SGD K)

81161151

Share Price History

DatePrice (SGD)ContextSource

5 Mar 2020

0.225

IPO placement price (pre-split; ≈0.075 split-adjusted)

Placement results

28 Apr 2021

0.23

Close after DTSS2 award

The Edge Singapore

3 Aug 2021

0.24

Start of the surge flagged by RegCo

SGX RegCo

12 Jan 2022

0.95

Peak flagged by RegCo (pre-split; ≈0.317 split-adjusted)

SGX RegCo

May 2025

0.009

Rights issue price

Rights terms

1 Aug 2025

0.013

Close before 1H2025 loss guidance

The Edge Singapore

9 Oct 2026

0.009

Latest close; 52-week range 0.006–0.014

StockAnalysis

Valuation Snapshot

MetricValueBasis

Shares outstanding

≈1,146.1 M

30 Jun 2026

Market capitalisation

≈S$10.3 M

StockAnalysis

Enterprise value

≈S$11.6 M

Market cap + borrowings S$7.76M + leases S$0.34M − cash S$6.81M (30 Jun 2026)

P/E (TTM)

n.m. (loss-making)

TTM net loss ≈S$8.75M attributable (StockAnalysis)

EV/EBITDA

n.m. (negative EBITDA)

—

EV/Sales (TTM)

≈0.65x

TTM revenue S$17.73M (2H2025 S$10.08M + 1H2026 S$7.65M)

P/B

≈3.6x

Attributable equity S$2.83M (30 Jun 2026)

Dividend metric

Dividend metricFY2021FY2022FY2023FY2024FY2025

Total dividend declared for year (SGD K)

4607801,29500

DPS split-adjusted (S$ cents)

0.0700.1180.19600

Payout ratio of attributable profit (%)

30.030.640.000

Share count (millions of shares)

Share count (millions of shares)FY2021FY2022FY2023FY2024FY2025

Shares in issue at year end split-adjusted (M)

660.771660.771660.771660.7711,142.964

Warrants outstanding at year end (M)

0000663.143

Capital Instruments

InstrumentDue within 1 year (SGD K)Due after 1 year (SGD K)

Invoice financing

8930

Term loans

1,4013,949

Short-term borrowing (third-party private lender)

1,5120

Revolving credit

00

Lease liabilities

225117

Total

4,031

4,066

Analyst Conclusions

Management guidance

No quantitative guidance. The latest commentary (1H2026 results, 13 Aug 2026) says the Group will:

  • pursue Singapore public and private membrane and MEICA work with stricter risk and return discipline;

  • pursue larger Indonesian EPC opportunities and new BOOTs through partnerships;

  • explore investment, JV and tendering opportunities in Vietnam;

  • operate "with prudence," monitoring IDR volatility closely.

AR2025 states that management aims to "stabilise and recover" through better project execution, cost efficiency, collection of final accounts and VOs, and equity and debt fundraising.

Consensus growth expectations

None available (no sell-side coverage).

Bull case (grounded in the data)

  1. VO and final-account recovery. VO claims on C22C and other delayed projects are excluded from both the accounts and management's cash-flow projections. Successful certification would fall directly to gross profit and cash. Against a S$10M market cap, even low-single-digit-million recoveries would be material.

  2. Recurring income inflection. SOW was the only meaningfully profitable segment in 1H2026 (S$201k on S$631k). Bali (80%) reaching commercial operation and Tanah Merah (42%) beginning sales could make concessions a stable earnings floor, with 15–25-year duration.

  3. Cost base reset and cash stabilisation. G&A fell 27.8% in 1H2026, operating cash flow turned positive (+S$3.4M), and borrowings fell 37.6% in six months (S$12.0M to S$7.8M). Once the loss-making Singapore contracts roll off, the remaining business could break even at lower revenue.

Bear case (grounded in the data)

  1. Equity is nearly exhausted. S$2.8M of attributable equity after a S$3.2M half-year loss leaves essentially no buffer. Another loss half-year at the 1H2026 run rate would wipe out book value, making further dilutive equity or deeper founder support likely.

  2. The franchise is shrinking. Revenue has fallen for five consecutive half-years to S$7.7M (1H2026). The order book was just S$15.9M at end-2025, with no major award since 2022. A constrained balance sheet limits the bonding capacity needed to win large PUB tenders.

  3. Governance and funding concentration. The CEO is simultaneously controlling shareholder, principal lender (12% loans), personal guarantor and the subject (with the former MD) of an unresolved CAD–MAS securities investigation. An adverse outcome could impair key relationships with PUB, banks and Indonesian SOE partners.

Key catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhy it matters
Certification and collection of VO claims and final accounts on C22C and DTSS2Ongoing; FY2026 resultsPrimary source of upside cash and margin
Bali BOOT commercial operation date announcement—Converts testing revenue into contracted SOW
Tanah Merah BOOT operating disclosure and first share of resultsFY2026–FY2027Recurring income contribution
New contract wins (PUB, Indonesian EPC, Vietnam)Any timeOrder book currently below one year of revenue
Covenant waiver renewals; refinancing of the third-party private loanFY2026 year endGoing-concern pivot
FY2026 results and audit opinion (any going-concern emphasis or modification)By ~1 Mar 2027 (results); ~Apr 2027 (AR)Audit treatment of liquidity
Further equity fundraising and warrant exerciseOngoingDilution vs balance-sheet repair
CAD–MAS investigation outcomeUnknownKey-person and reputational risk
IDR/SGD exchange rateContinuousTranslation losses on Indonesian net assets

Concluding analyst verdict

Memiontec shows how a technically capable specialist contractor can be undone by a few large fixed-price contracts. Between 2019 and 2022 the Group won the most prestigious work in its history — TSDP, DTSS2 and the S$56.6M C22C MBR package — and FY2023 brought record revenue of S$66.9M and a 15.8% return on equity. Those same contracts, signed before post-pandemic cost inflation, then consumed most of the Group's capital. Attributable equity fell from S$21.6M to S$2.8M in thirty months. Covenants broke, a rights issue diluted holders by two-thirds, and the founder became the Group's lender of last resort at 12%.

The positive signs are real but early. The worst Singapore contracts are substantially complete. Collections are converting contract assets into cash, producing a S$3.4M operating inflow in 1H2026. Overheads are falling. The Indonesian concession portfolio — Bali at 80%, Tanah Merah at 42%, plus Hutan Kota, Waduk Pluit and Pekanbaru — is finally contributing recurring water sales. Unrecognised VO claims are a free option on the upside.

The negatives are larger in near-term scale. The revenue base has collapsed to an annualised S$15–18M, and the order book is thin. Equity is close to zero, and management openly relies on lender waivers and controlling-shareholder support. An unresolved securities investigation also hangs over the two founders.

At ≈S$10M market value and ≈3.6x book, the equity is priced as an option on a successful recovery rather than as a going-concern earnings stream. The next twelve months — VO certification, Bali's commercial start, covenant renewal and the FY2026 audit opinion — will decide whether Memiontec stabilises as a small concession-plus-services water platform or needs another recapitalisation. Institutional mandates requiring balance-sheet resilience or clean governance should treat it as uninvestable until those catalysts resolve.


Data integrity statement: all figures are drawn from the named filings and sources. Where filings conflict (FY2022 and FY2023 unaudited vs audited; FY2023 segment notes; FY2025 D/E; PPTM injection amounts; concession capacities; FY2024 local procurement), both values are noted.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleFirst appointedLast re-electedBackground and education

Hor Siew Fu

Independent Non-Executive Chairman (Chairman since 22 Jul 2024)

30 Dec 2019

25 Apr 2025

Former CFO of Albedo Ltd (2014–2016) and CosmoSteel Holdings (2007–2013); Deutz MWM Asia Pacific (1984–1996); Keppel group (1976–1984). B.Acc (University of Singapore, 1976); MBA (Macquarie, 1994); FCA (ISCA); FCCA. ID of other SGX companies (per AR2024).

Tay Kiat Seng

Executive Director and CEO; co-founder; controlling shareholder

6 Mar 2013

29 Apr 2022 (seeking re-election 30 Apr 2026)

Co-founded the business in 1992. Previously senior manager at Watermac Engineering (2 years) and design engineer on MEMCOR membranes at Memtec Ltd, Australia (2 years). B.Eng (Mechanical), University of Strathclyde (1988); Stanford Scale-Up SG programme (2021).

Ling Chung Yee, Roy

Independent Non-Executive Director

22 Jul 2024

25 Apr 2025 (seeking re-election 30 Apr 2026)

20+ years of investment banking (JPMorgan, Lehman Brothers, Goldman Sachs, Salomon Smith Barney); CEO and founder of FollowTrade; adjunct at NUS/SMU/SUSS; ID of VinFast Auto and other listed companies (per AR2024). Global EMBA (INSEAD); BBA (Hons) (NUS).

Chua Siong Kiat

Non-Executive Non-Independent Director

26 Apr 2025

—

Group CFO from 28 Apr 2023 to 25 Apr 2025; founder of Lighthouse Business Consulting (2017); ID on three other SGX companies. FCCA, FCA (Singapore), CIA, CVA, SID Senior Accredited Director; MBA/DIC (Imperial College London).

Board of Directors — Soelistyo Dewi Soegiharto

NameFormer roleTenureExit

Soelistyo Dewi Soegiharto

Managing Director; co-founder; substantial shareholder; spouse of the CEO

6 Mar 2013 – 25 Apr 2025

Retired at the 2025 AGM; remains director of Memiontec Pte Ltd and other subsidiaries

Yap Chee Wee

Independent Director (founder of Fleur Capital)

1 Sep 2023 – 25 Apr 2025

Retired at the 2025 AGM

Board of Directors — Toh Kai En

NameRoleSinceBackground

Toh Kai En

Financial Controller (head of Group finance)

25 Apr 2025

Joined 2021 as Group Accountant; Group Finance Manager from May 2023; formerly Baker Tilly TFW (2017–2021); CA (Singapore); B.Acc (NTU, 2017)

Lim Wei Kuan

Director, Memiontec Pte Ltd

Director since Dec 2019 (with Group since 2006)

B.Eng (Chemical), University of Malaya (2006); responsible for Singapore design, sales, execution and P&L

Soelistyo Dewi Soegiharto

Director, Memiontec Pte Ltd

Co-founder (1992)

B.Eng (Chemical), UNSW (1991)

Irawati Tan

Director, PT Memiontec Indonesia

Joined 2009

Formerly with the Astel Group (budget/finance controller; procurement manager); B.Acc, Bina Nusantara University (2004)

Directors' Remuneration

Compensation item (SGD K)FY2021FY2022FY2023FY2024FY2025

Directors' remuneration in G&A (SGD K)

8021,088965528638

Directors' fees (SGD K)

148150139135145

Major Shareholders

HolderShares%Date / basisSource

Tay Kiat Seng (CEO), direct

296,676,888

44.9% of 660,771,000

31 Aug 2023 (pre-rights)

MarketScreener

Soelistyo Dewi Soegiharto

104,425,239

15.8% of 660,771,000 (analyst computation)

Pre-rights

Simply Wall St shareholder list

Unity Strength Pte. Ltd. (CEO is a director; CEO increased his stake in this entity per company disclosure)

79,369,662

12.0% of 660,771,000 (analyst computation)

Pre-rights

Simply Wall St; TipRanks news headline

Khee Seng Yeo

30,000,000

n/v

n/v

Simply Wall St

Zhi Ng

20,995,500

n/v

n/v

Simply Wall St

Futu Singapore Pte. Ltd. (only identifiable institution)

1,661,300

≈0.15%

n/v

Simply Wall St

Competitive Landscape

Competitors by Segment

Segment / marketCompetitorPositioning vs Memiontec

Singapore PUB water/wastewater EPC and MEICA

Koh Brothers Eco Engineering (SGX Catalist: 5HV)

Larger civil/water EPC contractor; involved at Tuas Water Reclamation Plant; much larger revenue base

Singapore PUB EPC

Keppel (Keppel Infrastructure / Keppel Seghers)

Integrated developer-operator of desalination and NEWater; vastly larger balance sheet

Singapore/regional water operations

Sembcorp Industries (water business)

Utility-scale water concessions and EPC; investment-grade scale

Singapore membrane plant EPC (legacy)

Hyflux (in liquidation; no longer a competitor)

Its exit reduced local competition for membrane packages

Singapore/Malaysia/PRC/Vietnam water EPC and O&M

Darco Water Technologies (SGX: BLR)

Closest listed micro-cap peer; industrial water EPC plus O&M; Vietnam water concession (Darco Ba Lai)

Global water EPC/technology

Veolia; SUEZ

Technology and O&M leaders on large municipal contracts

Indonesian state-owned EPC

PT Wijaya Karya (WIKA); PT Adhi Karya; PT PP (also a partner)

Dominant in large public water infrastructure; Memiontec typically partners with these SOEs

Indonesian water concessions

Moya Indonesia group (PT Aetra Air Jakarta and others)

Larger private water concession operator in Jakarta and Indonesia

PRC/Asia municipal water

China Everbright Water; SIIC Environment

Large Chinese municipal water operators; not present in Memiontec's core markets

Industrial water treatment

Kurita (Japan); Toray-linked engineering units

Industrial water chemistry and membranes; SDS-adjacent competition

Peer Comparison FY2025

MetricMemiontec (FY2025)Darco Water Technologies (FY2025)Koh Brothers Eco EngineeringKoh Brothers Group (parent of KBE, FY2025)

Revenue (SGD Mn)

25.951.4—329.4

Revenue growth (%)

-51.0-13.1

+68 (1H2025 YoY)

+38.2

Gross margin (%)

-6.512.3

12.4 (1H2025: S$13.9M on S$111.9M)

11.9

Operating margin (%)

-27.2

-10.0 (operating income −S$5.13M per S&P Global data)

n/v

n/v

Net income attributable (SGD Mn)

-9.5-4.85

3.04 (1H2025)

18.6

Market capitalisation (SGD Mn)

≈10.3 (Oct 2026)

≈7.5 (Simply Wall St, date n/v)

n/v

n/v

Company Snapshot

$19.8M

Revenue

1992

Founded

Singapore

Headquarters

SWOT Analysis

Strengths

  • Technical credentials with PUB. The Group has completed or substantially completed TSDP UF (8,800 L/s; S$33.2M), DTSS2 odour control (S$21.7M) and C22C Phase A MBR (S$56.6M, 22 MGD) (AR2025; contract announcements).
  • Regulatory licences. BCA ME11 L6 in Singapore, with no tender limit (AR2024), and B1/B2 construction licences in Indonesia (AR2024).
  • Recurring-income assets. Co-owner of five Indonesian BOOT/TOOT projects with 15–25-year concessions (AR2025); SOW segment result of S$201k in 1H2026, the Group's best-performing segment.
  • Indonesia profitability. Indonesian operations delivered profit in FY2024 and "stable and positive" contributions in FY2025 while Singapore lost money (AR2024; AR2025).
  • SDS momentum. SDS revenue grew nearly fivefold from S$456k (FY2021) to S$2.23M (FY2025); 1H2026 SDS revenue rose more than 100% (FY2025 and 1H2026 results).
  • Committed controlling shareholder. The CEO underwrote his full rights entitlement plus excess and has lent S$5M+ cumulatively since FY2024 (FY2024 and FY2025 results; 1H2026 results).

Weaknesses

  • Equity depletion. Group attributable equity fell from S$21.6M (FY2023) to S$2.8M (30 Jun 2026); NAV is 0.25 cents per share (1H2026 results).
  • Execution losses on fixed-price contracts. TSEPC segment losses were S$5.56M (FY2024) and S$6.13M (FY2025) (FY2025 results).
  • Leverage and covenant stress. D/E of 2.55x at 30 Jun 2026; covenant breaches in Feb 2025 and again at 30 Jun 2026, cured only by one-off waivers (1H2026 results).
  • Shrinking order book. S$105M (end-2022) to S$15.9M (end-2025); 1H2026 revenue of only S$7.7M (FY2022 and FY2025 results; 1H2026 results).
  • High-cost funding. Director loans at 12% p.a. and a third-party private lender loan; finance costs rose from S$0.13M (FY2023) to S$1.07M (FY2025) (FY2025 results).
  • Thin management bench and key-person dependence. No CFO since April 2025; the founding couple remain central to operations; the board has four members (AR2025).

Opportunities

  • Variation-order recovery. VO claims on C22C and other delayed projects have been submitted but are not recognised in the accounts or in cash-flow projections, so any certification is upside (AR2025; FY2025 results).
  • Bali desalination commercial operation. Converting testing-phase water sales into a full concession of at least 15 years (consolidated at 80%) would grow SOW (AR2025).
  • Tanah Merah ramp-up. A 42% stake in a 200 L/s, 20-year BOOT completed in 2025 (AR2025).
  • Singapore pipeline. About S$5B of Tuas Nexus packages, plus continued NEWater and WRP upgrades (AR2024 industry prospects).
  • Vietnam and Cambodia. Management cites demand for BOOTs with 50-year concessions (FY2025 results), and a subsidiary already exists.
  • Warrant proceeds. 659,977,215 warrants are outstanding at S$0.003; full exercise would raise ≈S$1.98M of equity (analyst computation from 1H2026 results).

Threats

  • Going-concern risk. The Board's going-concern conclusion depends on collections, lender support and controlling-shareholder support (1H2026 results note 1).
  • Regulatory investigation. The CAD–MAS joint investigation under SFA Section 201 involving the CEO and former MD remains unresolved publicly (SGXNet, Aug 2024).
  • IDR depreciation. Translation losses of S$1.47M (FY2025) and S$0.79M (1H2026), plus FX losses in G&A (S$0.46M in FY2025) (FY2025 and 1H2026 results).
  • Lower volumes at Hutan Kota. JV losses widened to S$0.62M in FY2025, with weather-related stoppages in 2023 (FY2023 and FY2025 results).
  • Indonesian foreign-ownership law. Consolidation of PTMP depends on Combination Agreements under Law No. 25 of 2007; a regulatory change could invalidate them (FY2025 results, section 14).
  • Dilution. Outstanding warrants equal 57.6% of issued shares, and management is "actively evaluating" further equity fundraising (1H2026 results; AR2025).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
opened Aug 2024*Status of the CAD–MAS investigation** no public update on charges or closure was found in the sources reviewed through 12 October 2026. The board's August 2024 position was that the investigation did not involve the Group and that both executives remained suitable to continue.

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

9 charts
Income Statement: Revenue & Gross Profit: Revenue fell from SGD 45.6 Mn in FY2021 to SGD 25.9 Mn in FY2025.
Memiontec Holdings Ltd. — Income Statement: Revenue & Gross Profit
Series (SGD Mn)FY2021FY2022FY2023FY2024FY2025
Revenue45.642.866.952.925.9
Cost of sales39.334.257.654.327.6
Gross profit6.38.69.3-1.4-1.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.